Dietary Quality and Relationships with Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD) among United States Adults, Results from NHANES 2017–2018

Abstract

Metabolic dysfunction-associated fatty liver disease (MAFLD) is a new definition for the evidence of hepatic steatosis and metabolic dysfunctions. The specific role of the dietary factors in the development and progress of the disease are not well illuminated. Thus, we conducted this study on the associations between dietary quality assessed by five dietary quality indexes (Dietary Inflammatory Index, DII; Mediterranean diet, MED; Dietary Approach to Stop Hypertension, DASH; Alternate Healthy Eating Index diet, AHEI; Healthy Eating Indices, HEI) and MAFLD phenotypes. This study was extracted from the latest NHANES 2017–2018 wave. Demographic information, health status, lifestyles, and dietary habits were reported in the questionnaire. Multivariate logistic regression and multivariate ordinal logistic regression methods were applied to explore the associations between dietary quality indexes and MAFLD or MAFLD with liver fibrosis. The weighted prevalence of Non-MAFLD, MAFLD without fibrosis, and MAFLD with fibrosis were 47.05%, 36.67%, and 16.28%, respectively, at the cutoff value of a median Controlled Attenuation Parameter (CAP) 248 dB/m and a median Liver Stiffness Measurement (LSM) 6.3 kPa. When the diagnostic cutoff values of CAP changed to 285 dB/m, the weighted prevalence of Non-MAFLD, MAFLD without liver fibrosis, and MAFLD with fibrosis turned to 64.62%, 22.08%, and 13.30%, respectively. All five dietary quality indexes, including DII, HEI-2015, AHEI, DASH, and MED, were all significantly associated with MAFLD phenotypes. DII was positively associated with MAFLD phenotypes, while other four dietary quality indexes, including HEI-2015, AHEI, DASH, and MED, were significantly associated with lower risk of MAFLD phenotypes. MAFLD is becoming a threatening public health concern among adult Americans and dietary quality is markedly associated with MAFLD phenotypes.

Higher serum chromium level may be associated with the presentation of depression in patients with metabolic dysfunction-associated fatty liver disease: evidence from NHANES survey

“…Educational attainment was categorized as either high school or lower, or higher than high school. Serum cotinine levels were used to categorize smoking into three tiers: minimal (<0.015 ng/mL), moderate (0.015-3 ng/mL), and significant (≥3 ng/mL) ( 36 – 38 ). Two 24-hour dietary recalls were used to gather information on daily alcohol consumption, and alcohol consumption was categorized as either never or having a drinking behavior ( 37 ).…”

Association of multiple serum minerals and vitamins with metabolic dysfunction-associated fatty liver disease in US adults: National Health and Nutrition Examination Survey 2017–2018

“…Based on education level, the patients were divided into less than high school, high school, and more than high school groups ( 22 ). Family income was assessed using the poverty income ratio (PIR), and the patients were classified into low-income (PIR < 1.30), middle-income (1.3 ≤ PIR < 3.5), and high-income (PIR ≥3.5) groups ( 23 ). Based on smoking status, the patients were divided into non-smoker (smoked less than 100 cigarettes in their lifetime) and smoker (smoked more than 100 cigarettes in their lifetime) groups.…”

Association between remnant cholesterol and insulin resistance levels in patients with metabolic-associated fatty liver disease

“…Notably, this cycle of NHANES introduced the assessment of liver function using ultrasound and vibration-controlled transient elastography (VCTE) for the first time. Liver steatosis was determined using a median Controlled Attenuation Parameter (CAP), while liver fibrosis was defined based on a median Liver Stiffness Measurement (LSM) 18 . The survey methodology included structured household interviews, which provided self-reported demographic data and medical records.…”